Advisornet Financial’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-319	Closed	-$7.34K	–	2343
2025 Q4	$7.34K	Buy	319 +231	+263%	+$7.6K	﹤0.01%	1636
2025 Q3	$2.65K	Sell	88 -609	-87%	-$18.3K	﹤0.01%	1812
2025 Q2	$25.3K	Buy	697 +137	+24%	+$4.94K	﹤0.01%	1198
2025 Q1	$20.3K	Buy	+560	New	+$23.3K	﹤0.01%	1184
2023 Q3	–	Sell	-1,500	Closed	-$69.2K	–	2397
2023 Q2	$69.2K	Hold	1,500	–	–	0.01%	736
2023 Q1	$60.1K	Hold	1,500	–	–	0.01%	747
2022 Q4	$69.5K	Hold	1,500	–	–	0.01%	714
2022 Q3	$62K	Hold	1,500	–	–	0.01%	794
2022 Q2	$89K	Hold	1,500	–	–	0.01%	706
2022 Q1	$109K	Hold	1,500	–	–	0.01%	725
2021 Q4	$126K	Hold	1,500	–	–	0.01%	716
2021 Q3	$135K	Hold	1,500	–	–	0.01%	690
2021 Q2	$143K	Hold	1,500	–	–	0.01%	686
2021 Q1	$171K	Hold	1,500	–	–	0.01%	598
2020 Q4	$208K	Hold	1,500	–	–	0.02%	496
2020 Q3	$123K	Hold	1,500	–	–	0.01%	620
2020 Q2	$117K	Hold	1,500	–	–	0.01%	630
2020 Q1	$67K	Hold	1,500	–	–	0.01%	711
2019 Q4	$64K	Sell	1,500 -1,350	-47%	-$55.7K	0.01%	812
2019 Q3	$122K	Hold	2,850	–	–	0.01%	620
2019 Q2	$181K	Hold	2,850	–	–	0.02%	470
2019 Q1	$198K	Hold	2,850	–	–	0.02%	430
2018 Q4	$124K	Buy	2,850 +650	+30%	+$35.5K	0.02%	473
2018 Q3	$168K	Hold	2,200	–	–	0.02%	451
2018 Q2	$169K	Hold	2,200	–	–	0.02%	427
2018 Q1	$112K	Hold	2,200	–	–	0.02%	504
2017 Q4	$102K	Buy	+2,200	New	+$108K	0.02%	478

Other funds holding RARE